Liquiritigenin alleviates doxorubicin-induced chronic heart failure via promoting ARHGAP18 and suppressing RhoA/ROCK1 pathway
Zhibing Xu, Zongde Hu, Hanchen Xu, Lifen Zhang, Liang Li, Yi Wang, Yuanqing Zhu, Limeng Yang, Dan Hu
Topics & Concepts
RHOAROCK1ApoptosisPharmacologyHeart failureCardiac function curveMedicineGene knockdownDoxorubicinBrain natriuretic peptideInternal medicineSignal transductionChemistryBiochemistryChemotherapyChemotherapy-induced cardiotoxicity and mitigationSignaling Pathways in DiseaseCardiac Fibrosis and Remodeling